Join

Compare · IBB vs JHB

IBB vs JHB

Side-by-side comparison of iShares Nasdaq Biotechnology Index Fund (IBB) and Nuveen High Income November 2021 Target Term Fund (JHB): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both IBB and JHB operate in n/a (n/a), so they compete in similar markets.
  • JHB carries a market cap of $525.4M.
MetricIBBJHB
Company
iShares Nasdaq Biotechnology Index Fund
Nuveen High Income November 2021 Target Term Fund
Price
$169.79-1.00%
$9.39+0.00%
Market cap
-
$525.4M
1M return
+2.47%
-
1Y return
+36.22%
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NYSE
IPO
n/a
2016
News (4w)
0
0
Recent ratings
0
0
IBB

iShares Nasdaq Biotechnology Index Fund

The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Latest IBB

Latest JHB